BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6151774)

  • 1. [Dynorphin: analgesic effect via kappa receptors in the spinal cord of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6151774
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid receptors mediating the antinociceptive effect of dynorphin at spinal cord level.
    Spampinato S; Candeletti S; Romualdi P; Speroni E; Cavicchini E; Spadaro C; Murari G; Giobbi G; Ferri S
    Ann Ist Super Sanita; 1984; 20(1):99-102. PubMed ID: 6152521
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
    [No Abstract]   [Full Text] [Related]  

  • 6. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine.
    Wood PL; Rackham A; Richard J
    Life Sci; 1981 May; 28(19):2119-25. PubMed ID: 6114371
    [No Abstract]   [Full Text] [Related]  

  • 8. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic activity of intraspinally administered dynorphin and ethylketocyclazocine.
    Piercey MF; Varner K; Schroeder LA
    Eur J Pharmacol; 1982 May; 80(2-3):283-4. PubMed ID: 6125400
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of kappa agonist.
    Kumor K; Su TP; Vaupel B; Haertzen C; Johnson RE; Goldberg S
    NIDA Res Monogr; 1986; 67():18-25. PubMed ID: 3018572
    [No Abstract]   [Full Text] [Related]  

  • 11. Analgesia induced by intrathecal injection of dynorphin B in the rat.
    Han JS; Xie GX; Goldstein A
    Life Sci; 1984 Apr; 34(16):1573-9. PubMed ID: 6371415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tritiated ethylketocyclazocine binding in rat brain: differential distribution of binding sites across brain regions.
    Hewlett WA; Akil H; Carlini W; Barchas JD
    Life Sci; 1982 Sep 20-27; 31(12-13):1351-4. PubMed ID: 6128657
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynorphin interaction at the kappa-opiate site.
    Huidobro-Toro JP; Yoshimura K; Lee NM; Loh HH; Way EL
    Eur J Pharmacol; 1981 Jun; 72(2-3):265-6. PubMed ID: 6113976
    [No Abstract]   [Full Text] [Related]  

  • 14. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible medullary kappa hyperalgesic mechanism. I. A new potential role for endogenous opioid peptides in pain perception.
    Wu KM; Martin WR; Kamerling SG; Wettstein JG
    Life Sci; 1983 Oct; 33(18):1831-8. PubMed ID: 6139722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential tolerance and cross-tolerance to chronic treatment with mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1984 Mar; 49():121-7. PubMed ID: 6090915
    [No Abstract]   [Full Text] [Related]  

  • 17. Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion.
    Valette A; Tafani M; Porthe G; Pontonnier G; Cros J
    Life Sci; 1983; 33 Suppl 1():523-6. PubMed ID: 6141498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of K-opiate sites by dynorphin in the myenteric plexus.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
    Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple opiate binding sites in rat spinal cord.
    Traynor JR; Kelly PD; Rance MJ
    Life Sci; 1982 Sep 20-27; 31(12-13):1377-80. PubMed ID: 6128660
    [No Abstract]   [Full Text] [Related]  

  • 20. Is dynorphin a k ligand?
    Lee NM
    Proc West Pharmacol Soc; 1983; 26():309-11. PubMed ID: 6136981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.